Ömür Tabak

1.3k total citations
45 papers, 646 citations indexed

About

Ömür Tabak is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Ömür Tabak has authored 45 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Surgery. Recurrent topics in Ömür Tabak's work include Liver Disease Diagnosis and Treatment (6 papers), Paraoxonase enzyme and polymorphisms (6 papers) and Diabetes Management and Research (5 papers). Ömür Tabak is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Paraoxonase enzyme and polymorphisms (6 papers) and Diabetes Management and Research (5 papers). Ömür Tabak collaborates with scholars based in Türkiye, United States and Denmark. Ömür Tabak's co-authors include Hafize Uzun, Füsun Erdenen, Remise Gelışgen, Hayriye Erman, Reşat Özaras, Hale Aral, Fehmı Tabak, Volkan Sözer, Veysel Tahan and Gülcan Güntaş and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Metabolism.

In The Last Decade

Ömür Tabak

40 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ömür Tabak Türkiye 16 170 165 133 109 93 45 646
Christian Schäfer Germany 16 172 1.0× 150 0.9× 94 0.7× 113 1.0× 110 1.2× 40 894
Emilie Blond France 15 179 1.1× 199 1.2× 96 0.7× 224 2.1× 87 0.9× 38 757
Tomás Meroño Argentina 16 95 0.6× 243 1.5× 218 1.6× 192 1.8× 140 1.5× 66 833
Suvarthi Das United States 17 424 2.5× 346 2.1× 137 1.0× 157 1.4× 70 0.8× 22 1.0k
Denise Frediani Barbeiro Brazil 20 173 1.0× 180 1.1× 70 0.5× 156 1.4× 209 2.2× 55 996
Rosalia Caldarella Italy 17 260 1.5× 120 0.7× 147 1.1× 143 1.3× 111 1.2× 50 829
Kalliopi Pafili Greece 14 334 2.0× 170 1.0× 291 2.2× 212 1.9× 165 1.8× 39 875
Christian von Loeffelholz Germany 18 301 1.8× 198 1.2× 149 1.1× 227 2.1× 136 1.5× 34 731
Nikolaj Rittig Denmark 17 122 0.7× 218 1.3× 238 1.8× 421 3.9× 118 1.3× 57 893
Hatice Yüksel Türkiye 19 103 0.6× 137 0.8× 35 0.3× 79 0.7× 101 1.1× 69 843

Countries citing papers authored by Ömür Tabak

Since Specialization
Citations

This map shows the geographic impact of Ömür Tabak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömür Tabak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömür Tabak more than expected).

Fields of papers citing papers by Ömür Tabak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ömür Tabak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömür Tabak. The network helps show where Ömür Tabak may publish in the future.

Co-authorship network of co-authors of Ömür Tabak

This figure shows the co-authorship network connecting the top 25 collaborators of Ömür Tabak. A scholar is included among the top collaborators of Ömür Tabak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ömür Tabak. Ömür Tabak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gelışgen, Remise, et al.. (2024). Dysfunction of PTEN-Associated MicroRNA Regulation: Exploring Potential Pathological Links in Type 1 Diabetes Mellitus. Medicina. 60(11). 1744–1744. 1 indexed citations
3.
Akarsu, Murat, et al.. (2022). Maternal serum preptin levels in the pathogenesis and diagnosis of Gestational diabetes mellitus. Journal of Medical Biochemistry. 42(2). 311–317.
4.
5.
Akarsu, Murat, et al.. (2022). Thrombospondin 1 and Nuclear Factor Kappa B Signaling Pathways in Non-alcoholic Fatty Liver Disease. Journal of Gastrointestinal and Liver Diseases. 31(3). 309–316. 5 indexed citations
6.
Bayram, Mehmet, et al.. (2021). Evaluation of hematological indices in terms of COVID-19 related mortality and ICU admission. Journal of Health Sciences and Medicine. 4(5). 666–669. 7 indexed citations
7.
Uzun, Hafize, et al.. (2021). Prognostic nutritional index as indicator of immune nutritional status of patients with COVID-19. International Journal for Vitamin and Nutrition Research. 92(1). 4–12. 11 indexed citations
8.
Bayram, Mehmet, et al.. (2021). Elevation of Serum Transaminase Levels Due to Favipiravir Use in the Treatment of COVID-19. Cureus. 13(9). e18166–e18166. 3 indexed citations
9.
10.
Seçkin, Kerem Doğa, et al.. (2019). Plasma Zonulin Levels as a Non-Invasive Biomarker of Intestinal Permeability in Women with Gestational Diabetes Mellitus. Biomolecules. 9(1). 24–24. 35 indexed citations
11.
Okuturlar, Yıldız, Hakan Koçoğlu, Oğuzhan Kuru, et al.. (2017). Plasma Urotensin II Concentration In Gestational Diabetes. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Sözer, Volkan, Hafize Uzun, Remise Gelışgen, et al.. (2013). The effects of atorvastatin on oxidative stress in L-NAME-treated rats. Scandinavian Journal of Clinical and Laboratory Investigation. 73(7). 591–597. 5 indexed citations
14.
Göksügür, Nadir, et al.. (2012). Carbamazepine-induced hypogammaglobulinemia. Seizure. 21(3). 229–231. 18 indexed citations
15.
Yılmaz, Mesut, et al.. (2011). Anorectal syphilis mimicking Crohn’s disease. Journal of Infection and Chemotherapy. 17(5). 713–715. 13 indexed citations
16.
Tabak, Ömür, Remise Gelışgen, Hayriye Erman, et al.. (2011). Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clinical and investigative medicine. 34(3). E163–E171. 106 indexed citations
17.
Canbakan, Billur, Tayfur Toptaş, Ömür Tabak, et al.. (2010). Validation of Biochemical Markers for the Prediction of Liver Fibrosis and Necroinflammatory Activity in Hemodialysis Patients with Chronic Hepatitis C. Nephron Clinical Practice. 117(3). c289–c295. 14 indexed citations
18.
Erdenen, Füsun, Ahmet Burak Toros, Hasan Bektaş, et al.. (2009). Diagnostic and prognostic value of tumor M2-pyruvate kinase levels in patients with colorectal cancer. The Turkish Journal of Gastroenterology. 24(1). 36–42. 17 indexed citations
19.
Tabak, Fehmı, Feyza Gündüz, Veysel Tahan, Ömür Tabak, & Reşat Özaras. (2008). Sertraline Hepatotoxicity: Report of a Case and Review of the Literature. Digestive Diseases and Sciences. 54(7). 1589–1591. 19 indexed citations
20.
Tabak, Ömür, et al.. (2007). A vertebral hydatid cyst infection mimicking tuberculous spondylodiscitis. Journal of Infection and Chemotherapy. 13(3). 180–182. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026